Rising Biosciences (OTC: RBII) operates four distinct business units. The first business unit is a physicians practice management company focused on the proper use of alternative medicines for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.  The fourth unit, Oxi-Thyme™ was developed to help fight the spread of Covid-19 and other harmful viruses and bacteria.  By utilizing a proprietary formulated EPA registered disinfectant with a touch-free delivery system, Oxi-Thyme™ has been able to help businesses across America safe and effectively fight the spread of deadly viruses.